Long-term results of Gamma Knife surgery for optic nerve sheath meningioma

Dong Liu1, Desheng Xu, Zhiyuan Zhang

  • 1Department of Neurosurgery, Tianjin Medical University Second Hospital, Hexi District, Tianjin, People's Republic of China.

Journal of Neurosurgery
|December 3, 2010
PubMed
Abstract

Insights

Gamma Knife surgery (GKS) offers long-term tumor control for optic nerve sheath meningioma (ONSM). This study shows GKS is a safe and effective treatment option for selected ONSM patients, with good tumor regression and stable vision outcomes.

Area of Science:

  • Neurosurgery
  • Radiation Oncology
  • Ophthalmology

Background:

  • Optic nerve sheath meningiomas (ONSM) are rare tumors affecting vision.
  • Long-term outcomes of Gamma Knife surgery (GKS) for ONSM require further evaluation.

Purpose of the Study:

  • To assess the long-term efficacy and safety of Gamma Knife surgery (GKS) for treating optic nerve sheath meningiomas (ONSM).

Main Methods:

  • Retrospective analysis of 30 patients with ONSM treated with GKS between 1998-2003.
  • Tumor volumes ranged from 1.4-9.7 cm³, with a mean peripheral dose of 13.3 Gy.
  • Median follow-up was 56 months.

Main Results:

  • Tumor control achieved in 28/30 patients; regression in 20, stable in 8.
  • Visual acuity improved in 11, remained stable in 13, and deteriorated in 6 patients.
  • Only reversible conjunctival edema observed as a side effect.

Conclusions:

  • Gamma Knife surgery provides durable tumor control for ONSM.
  • GKS is a safe and effective treatment option for selected ONSM cases.
  • Results support GKS as a potential standard treatment for ONSM.

Related Concept Videos